Trends in Corticosteroid Injections for Treatment of Lateral Epicondylitis: An Analysis of 80,169 Patients

Introduction: Corticosteroid (CS) injections are a frequently used treatment modality for lateral epicondylitis (LE) despite an increasing number of studies suggesting their lack of efficacy. The objective of this study was to review the annual utilization of CS injections for treatment of LE, as well as that of other nonsurgical treatments and surgical treatments, to understand how recent publications have affected the practice of physicians in treating LE. Methods: Patients with LE from 2010 to 2017 were identified within a national insurance database and grouped by treatment modalities of CS injections, physical therapy, bracing treatment, and surgery. Epidemiologic and demographic data were reported using descriptive statistics. The number of patients receiving each treatment and the number of CS injections per patient were quantified for each year, and annual trends were analyzed using logistic regression. Results: Among 80,169 qualifying patients, 16,476 received CS injections, 12,180 received physical therapy, 1,874 received bracing treatment, and 2,650 underwent surgery, with patients receiving multiple modalities being members of each respective group. We found a significant decrease in the proportion of patients with LE receiving CS injections from 23.3% in 2010 to 18.8% in 2017 (R2 = 0.956, P < 0.001). Interestingly, the number of CS injections per patient increased during this period from 1.33 to 1.83 (R2 = 0.843, P = 0.001). No notable changes in utilization trends for other modalities were found. Discussion: Overall, our data support a decline in the use of CS injection as a treatment modality for LE from 2010 to 2017. Although correlational, this trend may reflect the increasing body of published evidence demonstrating the ineffectiveness of CS injections for the treatment of LE. In addition, the increasing number of injections per patient among those who received injections contrasts with the overall decrease in steroid utilization among all patients. Further study is needed to fully understand the mechanisms behind these trends.

[1]  R. Duncan,et al.  Lateral epicondylitis: the condition and current management strategies. , 2019, British journal of hospital medicine.

[2]  J. Callaghan,et al.  Impact of Clinical Practice Guidelines on Use of Intra-Articular Hyaluronic Acid and Corticosteroid Injections for Knee Osteoarthritis , 2018, The Journal of bone and joint surgery. American volume.

[3]  K. Chung,et al.  The Effect of Impactful Articles on Clinical Practice in the United States: Corticosteroid Injection for Patients with Lateral Epicondylitis , 2018, Plastic and reconstructive surgery.

[4]  Joshua D. Harris,et al.  Open, Arthroscopic, and Percutaneous Surgical Treatment of Lateral Epicondylitis: A Systematic Review , 2018, Hand.

[5]  Christopher L. Camp,et al.  Factors That Increase the Risk of Infection After Elbow Arthroscopy: Analysis of Patient Demographics, Medical Comorbidities, and Steroid Injections in 2,704 Medicare Patients. , 2017, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[6]  Waqas M. Hussain,et al.  Changes Within Clinical Practice After a Randomized Controlled Trial of Knee Arthroscopy for Osteoarthritis , 2017, Orthopaedic journal of sports medicine.

[7]  Christopher L. Camp,et al.  Three or more preoperative injections is the most significant risk factor for revision surgery after operative treatment of lateral epicondylitis: an analysis of 3863 patients. , 2017, Journal of shoulder and elbow surgery.

[8]  B. Morrey,et al.  Health Care Utilization and Direct Medical Costs of Tennis Elbow , 2016, Sports health.

[9]  L. Bisset,et al.  Economic evaluation favours physiotherapy but not corticosteroid injection as a first-line intervention for chronic lateral epicondylalgia: evidence from a randomised clinical trial , 2015, British Journal of Sports Medicine.

[10]  C. Kahlenberg,et al.  New Developments in the Use of Biologics and Other Modalities in the Management of Lateral Epicondylitis , 2015, BioMed research international.

[11]  R. Strauch,et al.  Does Nonsurgical Treatment Improve Longitudinal Outcomes of Lateral Epicondylitis Over No Treatment? A Meta-analysis , 2015, Clinical orthopaedics and related research.

[12]  R. Lador,et al.  Lateral epicondylitis treatment: international survey of surgeons' preferences and literature review , 2014, International journal of clinical practice.

[13]  J. Elfar,et al.  Non-surgical treatment of lateral epicondylitis: a systematic review of randomized controlled trials , 2014, Hand.

[14]  L. Bisset,et al.  Effect of corticosteroid injection, physiotherapy, or both on clinical outcomes in patients with unilateral lateral epicondylalgia: a randomized controlled trial. , 2013, JAMA.

[15]  Samuel A. Taylor,et al.  Evaluation and Management of Elbow Tendinopathy , 2012, Sports health.

[16]  A. Matson,et al.  A Review of Modern Management of Lateral Epicondylitis , 2012, The Physician and sportsmedicine.

[17]  C. Cooper,et al.  Occupation and epicondylitis: a population-based study. , 2012, Rheumatology.

[18]  Kelli R. Snyder,et al.  Effectiveness of corticosteroids in the treatment of lateral epicondylosis. , 2012, Journal of sport rehabilitation.

[19]  L. Hart.  Corticosteroid and other injections in the management of tendinopathies: a review. , 2011, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.

[20]  J. Orchard.  Corticosteroid injection for lateral epicondylalgia is helpful in the short term, but harmful in the longer term; data for non-corticosteroid injections and other tendinopathies are limited , 2011, Evidence Based Medicine.

[21]  L. Bisset,et al.  Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomised controlled trials , 2010, The Lancet.

[22]  H. Osborne.  Stop injecting corticosteroid into patients with tennis elbow, they are much more likely to get better by themselves! , 2010, Journal of science and medicine in sport.

[23]  Eira Viikari-Juntura,et al.  Prevalence and determinants of lateral and medial epicondylitis: a population study. , 2006, American journal of epidemiology.

[24]  Chad D. Hosemann,et al.  Tendinosis of the extensor carpi radialis brevis: an evaluation of three methods of operative treatment. , 2006, Journal of shoulder and elbow surgery.

[25]  L. Bouter,et al.  Lateral epicondylitis in general practice: course and prognostic indicators of outcome. , 2006, The Journal of rheumatology.

[26]  L. Bisset,et al.  Mobilisation with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: randomised trial , 2006, BMJ : British Medical Journal.

[27]  J. H. Andersen,et al.  Prognostic factors in lateral epicondylitis: a randomized trial with one-year follow-up in 266 new cases treated with minimal occupational intervention or the usual approach in general practice. , 2003, Rheumatology.

[28]  Rachelle Buchbinder,et al.  Corticosteroid injections for lateral epicondylitis: a systematic review , 2002, Pain.

[29]  L. Bouter,et al.  Corticosteroid injections, physiotherapy, or a wait-and-see policy for lateral epicondylitis: a randomised controlled trial , 2002, The Lancet.

[30]  P. Croft,et al.  Pragmatic randomised controlled trial of local corticosteroid injection and naproxen for treatment of lateral epicondylitis of elbow in primary care , 1999, BMJ.

[31]  B. Kraushaar,et al.  Current Concepts Review - Tendinosis of the Elbow (Tennis Elbow). Clinical Features and Findings of Histological, Immunohistochemical, and Electron Microscopy Studies* , 1999 .

[32]  J. Verhaar.  Tennis elbow. Anatomical, epidemiological and therapeutic aspects. , 1994, International orthopaedics.

[33]  R. Nirschl.  Elbow tendinosis/tennis elbow. , 1992, Clinics in sports medicine.

[34]  T Gibson,et al.  Local injection treatment of tennis elbow--hydrocortisone, triamcinolone and lignocaine compared. , 1991, British journal of rheumatology.

[35]  M. Driessens,et al.  A retrospective study of the conservative treatment of tennis-elbow. , 1990, Acta Belgica. Medica physica : organe officiel de la Societe royale belge de medecine physique et de rehabilitation.

[36]  R. Coonrad,et al.  Tennis elbow: its course, natural history, conservative and surgical management. , 1973, The Journal of bone and joint surgery. American volume.

[37]  J. Lahz.  Pathology and treatment of tennis elbow. , 1948, The Journal of bone and joint surgery. British volume.